Unick KRX:011320KOSDAQ
유니크 · Korean news coverage and regulatory filings, organized.
Articles, 24h2
Articles, 7 days11
DART filings, 7 days1
Articles tracked11since Sep 11
In Q2 2026, Unick reported revenue of ₩121bn, up 12.7% year on year, and operating profit of ₩4.9bn. Unick (유니크) appeared in 11 Korean news articles and 1 DART filing over the past seven days. Coverage peaked on Sep 14 with 9 articles.
Unick quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩121bn | +12.7% | ₩4.9bn | ₩4.6bn |
| Q1 2026 | ₩112bn | +9.4% | ₩5.1bn | ₩4.8bn |
| Q4 2025 derived | ₩110bn | +11.2% | ₩1.1bn | ₩886m |
| Q3 2025 | ₩110bn | +14.9% | ₩4.5bn | ₩3.9bn |
| Q2 2025 | ₩108bn | +16.8% | ₩5.5bn | ₩3.8bn |
| Q1 2025 | ₩102bn | +16.5% | ₩3.3bn | ₩2.2bn |
| Q4 2024 derived | ₩99.1bn | +15.8% | −₩1.5bn | ₩1.7bn |
| Q3 2024 | ₩95.5bn | +15.2% | ₩2.6bn | ₩1.1bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.
Unick top stories 2 weeks, by number of outlets
- 1
- 2
- 3
- 4
- 5
- 6
Latest Unick news Korean headlines
-
자생메디바이오센터, 성남시 ‘유니크 베뉴’ 선정
5 more on this story · 5 outlets
- 자생메디바이오센터, 성남시 ‘유니크 베뉴’ 선정…‘MICE 거점’ 도약뉴시안 · Sep 14 10:01
- 자생메디바이오센터, 성남시 '유니크 베뉴' 선정포인트데일리 · Sep 14 10:08
- 자생메디바이오센터, 성남시 '유니크 베뉴' 선정…한의약 체험 연계KPI뉴스 · Sep 14 10:11
- 자생메디바이오센터, 성남시 ‘유니크 베뉴’ 육성 사업 선정라포르시안 · Sep 14 10:26
- 자생메디바이오센터, 성남 유니크 베뉴 선정불교방송 · Sep 14 13:37